Seoul, South Korea · Founded 2017 · Privately Held (backing)
Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. ExoCoBio is based in Seoul, South Korea and was founded in 2017. Its last known valuation is $510,000. It has raised $55.3 million.
Last price · $/share
—
Implied valuation
$510K
Total raised
$55.3M
Last round
—
Team — not yet on record
No current team members for ExoCoBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ExoCoBio with a free account
·The complete investor list: 20 names
·Watch ExoCoBio: the Monday email on marks, rounds and moves
